series-c-plus
Stage
1
Investors
About
Enanta Pharmaceuticals is a biotechnology company that discovers and develops small molecule drugs targeting viral infections and liver diseases, including therapies for hepatitis C virus and respiratory syncytial virus.
Explore Enanta Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.